SIGIRR Genetic Variants in Premature Infants with Necrotizing Enterocolitis
Functional studies carried out in human embryonic kidney cells and intestinal epithelial cells demonstrated that SIGIRR inhibited inflammation induced by lipopolysaccharide, a cell wall component of Gram-negative bacteria implicated in necrotizing enterocolitis. [Pediatrics] Abstract
Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
INDUSTRY NEWS
Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies
Eli Lilly and Company and Sanford-Burnham Medical Research Institute will investigate potential therapeutics using biotechnology approaches in targeting multiple immune checkpoint modulators for the treatment of immunological diseases such as lupus, Sjögren’s Syndrome, inflammatory bowel disease and other autoimmune disorders. [Eli Lilly and Company] Press Release
Recruit Top Talent: Reach more than 60,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Intestinal Cell News? Click here to submit!